BRIEF-Moleculin Biotech-audit committee determined co's financial statements for quarter ended June 30, 2016 should no longer be relied upon
November 18, 2016 at 17:27 PM EST
* Moleculin Biotech - a liability in amount of $750,000 should not have been reflected in balance sheet as of June 30, 2016
